Harrow (HROW) Other financing activities (2015 - 2026)

Harrow (HROW) recorded quarterly Other financing activities of $113000.0 in Q1 2026, up 145.65% quarter-over-quarter from $46000.0 in Q4 2025.

Harrow (HROW) Other financing activities (2015 - 2026) Analysis & Trends

Harrow's Other financing activities history runs 8 years deep, the most recent figure standing at $113000.0 for Q1 2026.

In Q1 2026, Other financing activities changed N/A year-over-year to $113000.0; the TTM figure through Mar 2026 stood at $159000.0 (changed N/A YoY), while the FY2025 annual figure was $1.6 million, changed N/A from the prior year.
Other financing activities was $113000.0 for Q1 2026 at Harrow, up from $46000.0 in the prior quarter.
In the past five years, Other financing activities ranged from a high of $113000.0 in Q1 2026 to a low of $46000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn
10	Harrow	1.25 Bn	1.15 Bn	27.05 Mn

Download Data